We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Capillary Zone Electrophoresis Developed for Rapid Determination of Thalassemia

By LabMedica International staff writers
Posted on 10 Jun 2015
A capillary zone electrophoresis (CZE) method has been developed for human globin determination in the diagnosis of thalassemia and hemoglobin variants as analysis of globin chains is an important aspect of thalassemia diagnostics. More...


Thalassemia is an inherited autosomal recessive blood disorder characterized by the underproduction of globin chains as a consequence of globin gene defects, resulting in malfunctioning red blood cells and oxygen transport.

Medical scientists at the Southern Medical University (Guangzhou, China) evaluated an assay on blood samples obtained from anticoagulated whole blood from a total of 310 clinical samples consisting of 58 normal, 107 α-thalassemia silent/trait, 42 β-thalassemia carriers and 63 β-thalassemia major and β-thalassemia intermedia (β -TM/TI), and 40 others with various hemoglobinopathies.

Hemoglobin analysis was carried out using the high-performance liquid chromatography (HPLC, Variant II, Bio-Rad Laboratories; Hercules, CA, USA). Capillary zone electrophoresis (CZE) was performed using a P/ACE MDQ Capillary Electrophoresis System (Beckman Coulter Inc.; Fullerton, CA, USA) equipped with a 70 cm × 50 μm uncoated fused-silica capillary at 25 °C.

Distinct globin peaks were resolved in 17 minutes and coefficients of variation (CV) for migration time and areas ranged from 0.37% to 1.69% and 0.46% to 6.71%, respectively. Receiver operating characteristic (ROC) curve analysis of the α/β area ratios gave 100% sensitivity and specificity for indicating β-TI/TM, and 100% sensitivity and 97.4% specificity for Hb H disease. Hemoglobin G-Honolulu (Hb G-Honolulu) and Hb Westmead (Hb WS) were successfully detected using this CZE method.

The authors concluded that they had successfully developed a simple, rapid, high-resolution CZE method for the separation of globin chains using highly acidic buffer and uncoated capillaries. Using this method, α-, β- and γ-chains, and αWS and αG Honolulu  chains were successfully separated within 17 minutes, indicating suitability for routine clinical applications. The migration times and globin chain peak areas were highly reproducible; although not as rapid as existing high-throughput HPLC techniques. This CZE method may provide an attractive complementary and/or confirmatory approach. The study was published in the June 2015 issue of the journal Blood Cells Molecules and Diseases.

Related Links:

Southern Medical University 
Bio-Rad Laboratories  
Beckman Coulter Inc.



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.